BackgroundCheck.run
Search For

Perry Michael Novak, 63476 Countryside Dr, Rolla, MO 65401

Perry Novak Phones & Addresses

476 Countryside Dr, Rolla, MO 65401   

35 Debbie Ln, Milford, MA 01757    508-4781737   

Ann Arbor, MI   

Ypsilanti, MI   

Pompano Beach, FL   

Lincoln, NE   

Conyers, GA   

476 Countryside Dr, Rolla, MO 65401    508-4781737   

Social networks

Perry Michael Novak

Linkedin

Work

Company: Brewer science Sep 1, 2011 Position: Senior technologist

Education

Degree: Master of Science, Masters School / High School: University of Nebraska - Lincoln 1984 to 1987 Specialities: Organic Chemistry

Skills

Custom Synthesis • Organic Chemistry • Medicinal Chemistry • Chemistry • Gmp • Lc Ms • Hplc • Technology Transfer • R&D • Chromatography • Analytical Chemistry • Nmr • Organic Synthesis • Drug Discovery • Mass Spectrometry • Purification • Uv/Vis • Laboratory • Glp • Drug Development • Biochemistry • Assay Development

Industries

Research

Mentions for Perry Michael Novak

Perry Novak resumes & CV records

Resumes

Perry Novak Photo 25

Senior Technologist

Location:
Rolla, MO
Industry:
Research
Work:
Brewer Science
Senior Technologist
Amgen Dec 2001 - Jul 2010
Senior Scientist
Kinetix Pharmaceuticals Jan 1998 - Dec 2001
Staff Scientist
Vertex Pharmaceuticals Dec 1992 - Jan 1998
Scientist
Warner Lambert 1987 - Dec 1992
Senior Associate Scientist
Education:
University of Nebraska - Lincoln 1984 - 1987
Master of Science, Masters, Organic Chemistry
Nebraska Wesleyan University 1980 - 1984
Bachelors, Bachelor of Science, Chemistry
Crete Jr/Sr High School
University of Nebraska–Lincoln
Skills:
Custom Synthesis, Organic Chemistry, Medicinal Chemistry, Chemistry, Gmp, Lc Ms, Hplc, Technology Transfer, R&D, Chromatography, Analytical Chemistry, Nmr, Organic Synthesis, Drug Discovery, Mass Spectrometry, Purification, Uv/Vis, Laboratory, Glp, Drug Development, Biochemistry, Assay Development

Publications & IP owners

Us Patents

Inhibitors Of Impdh Enzyme

US Patent:
6344465, Feb 5, 2002
Filed:
Feb 14, 1997
Appl. No.:
08/801780
Inventors:
David M. Armistead - Maynard MA
Michael C. Badia - Bedford MA
Guy W. Bemis - Arlington MA
Randy S. Bethiel - Allston MA
Catharine A. Frank - Marlborough MA
Perry M. Novak - Milford MA
Steven M. Ronkin - Watertown MA
Jeffrey O. Saunders - Acton MA
Assignee:
Vertex Pharmaceuticals, Incorporated - Cambridge MA
International Classification:
A61K 31445
US Classification:
514326, 514340, 514374, 546208, 5462714, 548236
Abstract:
The present invention relates to a novel class of compounds which are IMPDH inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting IMPDH enzyme activity and consequently, may be advantageously used as therapeutic agents for IMPDH mediated processes. This invention also relates to methods for inhibiting the activity of IMPDH using the compounds of this invention and related compounds.

Kinase Inhibitors

US Patent:
6495558, Dec 17, 2002
Filed:
Mar 21, 2000
Appl. No.:
09/528976
Inventors:
David M. Armistead - Sudbury MA
Jean E. Bemis - Arlington MA
Daniel Elbaum - Newton MA
Gregory J. Habgood - Merrimac MA
Perry M. Novak - Milford MA
Joseph J. Nunes - Andover MA
Leticia M. Toledo-Sherman - Somerville MA
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
C09D23936
US Classification:
514272, 544321
Abstract:
The invention relates to inhibitors of kinases, compositions comprising the inhibitors, and methods of using the inhibitors and inhibitor compositions. The inhibitors and compositions comprising them are useful for treating disease or disease symptoms. The invention also provides for methods of making kinase inhibitor compounds, methods of inhibiting kinase activity, and methods for treating disease or disease symptoms.

Inhibitors Of Impdh Enzyme

US Patent:
6518291, Feb 11, 2003
Filed:
Sep 14, 1999
Appl. No.:
09/395798
Inventors:
Jeffrey O. Saunders - Acton MA
David M. Armistead - Sudbury MA
Michael C. Badia - Bedford MA
Randy S. Bethiel - Cambridge MA
Catherine A. Frank - Langhorne PA
Doug Naegele - Washington DC
Perry M. Novak - Milford MA
David A. Pearlman - Arlington MA
Steven M. Ronkin - Watertown MA
Assignee:
Vertex Pharmaceuticals, Incorporated - Cambridge MA
International Classification:
A61K 31136
US Classification:
514367, 514375, 514388, 514415, 514443, 514452, 514466, 514470, 514657, 548161, 548222, 5483074, 548483, 549 57, 549439, 549467, 564428
Abstract:
The present invention relates to a novel class of compounds which are IMPDH inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting IMPDH enzyme activity and consequently, may be advantageously used as therapeutic agents for IMPDH mediated processes. This invention also relates to methods for inhibiting the activity of IMPDH using the compounds of this invention and related compounds.

Inhibitors Of Impdh Enzyme

US Patent:
6541496, Apr 1, 2003
Filed:
Apr 24, 2000
Appl. No.:
09/556253
Inventors:
David M. Armistead - Maynard MA
Michael C. Badia - Bedford MA
Guy W. Bemis - Arlington MA
Randy S. Bethiel - Bedford MA
Catharine A. Frank - Langhorne PA
Perry M. Novak - Milford MA
Steven M. Ronkin - Watertown MA
Jeffrey O. Saunders - Acton MA
Assignee:
Vertex Pharmaceuticals Incorporated - Cambridge MA
International Classification:
A61K 3142
US Classification:
514374
Abstract:
The present invention relates to a novel class of compounds which inhibit IMPDH. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting IMPDH enzyme activity and consequently, may be advantageously used as therapeutic agents for IMPDH mediated processes. This invention also relates to methods for inhibiting the activity of IMPDH using the compounds of this invention and related compounds.

Inhibitors Of Impdh Enzyme Technical Field Of The Invention

US Patent:
6653309, Nov 25, 2003
Filed:
Oct 30, 2000
Appl. No.:
09/702991
Inventors:
Jeffrey O. Saunders - Acton MA
Daniel Elbaum - Newton MA
Perry M. Novak - Milford MA
Douglas Naegele - Washington DC
Randy S. Bethiel - Cambridge MA
Steven M. Ronkin - Watertwon MA
Michael C. Badia - Bedford MA
Catharine Frank - Langhorne PA
Dean P. Stamos - Framingham MA
William Walters - Waltham MA
David Pearlman - Arlington MA
Assignee:
Vertex Pharmaceuticals Incorporated - Cambridge MA
International Classification:
C07D25102
US Classification:
514242, 564100, 564161, 564162, 564163, 564168, 564169, 564173, 514249, 51425201, 51425505, 5142521, 5142581, 5142631, 5142632, 514269, 514299, 514300, 514345, 514306, 514307, 514311, 514336, 514363, 514365, 514372, 514374, 514378, 514383, 514406, 514438, 514469, 514476
Abstract:
The present invention relates to compounds which inhibit IMPDH. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well-suited for inhibiting IMPDH enzyme activity and consequently, may be advantageously used as therapeutic agents for IMPDH mediated processes. This invention also relates to methods for inhibiting the activity of IMPDH using the compounds of this invention and related compounds.

Substituted Triazinyl Acrylamide Derivatives And Methods Of Use

US Patent:
6881737, Apr 19, 2005
Filed:
Apr 10, 2002
Appl. No.:
10/120959
Inventors:
John L. Buchanan - Brookline MA, US
Joseph L. Kim - Wayland MA, US
Perry M. Novak - Milford MA, US
Joseph J. Nunes - Andover MA, US
Vinod F. Patel - Acton MA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
C07D251/16
C07D251/18
A61K031/53
A61P035/00
A61P013/12
US Classification:
514241, 544207, 544208, 544209, 544211, 544212, 544213
Abstract:
The invention encompasses compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions, uses and methods for prophylaxis and treatment of cancer and polycystic kidney disease.

Substituted Pyrimidinyl Derivatives And Methods Of Use

US Patent:
6939874, Sep 6, 2005
Filed:
Aug 21, 2002
Appl. No.:
10/225783
Inventors:
Jean-Christophe Harmange - Andover MA, US
John L. Buchanan - Brookline MA, US
Stuart Chaffee - Cambridge MA, US
Perry M. Novak - Milford MA, US
Simon Van Der Plas - Kanata, CA
Xiaotian Zhu - Newton MA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
C07D401/14
A61K031/4709
US Classification:
514275, 544324
Abstract:
The invention encompasses compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions, uses and methods for prophylaxis and treatment of cancer.

Inhibitors Of Impdh Enzyme

US Patent:
6967214, Nov 22, 2005
Filed:
Jan 23, 2003
Appl. No.:
10/351731
Inventors:
David M. Armistead - Sudbury MA, US
Michael C. Badia - Bedford MA, US
Guy W. Bemis - Arlington MA, US
Randy S. Bethiel - Cambridge MA, US
Catharine A. Frank - Langhorne PA, US
Perry M. Novak - Milford MA, US
Steven M. Ronkin - Watertown MA, US
Jeffrey O. Saunders - Acton MA, US
Assignee:
Vertex Pharmaceuticals Incorporated - Cambridge MA
International Classification:
A61K031/42
A61P031/22
US Classification:
514374
Abstract:
The present invention relates to a novel class of compounds which are IMPDH inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting IMPDH enzyme activity and consequently, may be advantageously used as therapeutic agents for IMPDH mediated processes. This invention also relates to methods for inhibiting the activity of IMPDH using the compounds of this invention and related compounds.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.